No Data
No Data
Breast Cancer Canada Launches $1M Fellowship To Expand Research Funding
With a new fellowship and a series of distinct funding initiatives, Breast Cancer Canada and its partners continue to push the boundaries of research with the goal of ending breast cancer sooner.
AstraZeneca's Tagrisso Gains Approval in Canada for NSCLC
AstraZeneca: Acquisition Includes $800M Upfront at Deal Closing
AstraZeneca: Acquisition Includes $800M Upfront at Deal
AstraZeneca: Amolyt Pharma's Total Consideration of Up to $1.05B
AstraZeneca: Amolyt Pharma's Total Consideration of Up to $1.05
AstraZeneca: Acquisition Bolsters Alexion Rare Disease Late-Stage Pipeline
AstraZeneca: Acquisition Bolsters Alexion Rare Disease Late-Stage
AstraZeneca PLC Acquisition of Amolyt Pharma Completed
AstraZeneca PLC Acquisition of Amolyt Pharma
No Data